APEXA TRIVEDI: Open Payments
NPI 1114632775 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,306 in 66 payments from 17 companies in 2025. Trend: 2023 $299 · 2024 $934 · 2025 $1,306
Food & beverage: $1,306
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $274 |
| AstraZeneca Pharmaceuticals LP | 9 | $208 |
| Xeris Pharmaceuticals, Inc. | 7 | $155 |
| Astellas Pharma US Inc | 4 | $111 |
| Amgen Inc. | 5 | $89 |
| Abbott Laboratories | 4 | $74 |
| Lilly USA, LLC | 4 | $73 |
| Boston Scientific Corporation | 2 | $69 |
| Exact Sciences Corporation | 2 | $49 |
| Phathom Pharmaceuticals, Inc. | 2 | $40 |
Products named: GVOKE HYPOPEN, AIRSUPRA, Ozempic, Veozah, FREESTYLE LIBRE 3, FARXIGA, BodyGuardian, Rybelsus.
Industry payments across OH — which companies pay providers there.
